Tradestie Institutional Equity Comparison Engine
EKSO vs PLSE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PLSE Overall Edge
PLSE Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulse Biosciences, Inc Common Stock (DE) (PLSE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EKSO trades at N/M Forward P/E with -119.7% operating margin (-38.3% YoY revenue) versus PLSE at N/M Forward P/E and -5861.2% operating margin (+359.3% YoY). In options structure, EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLSE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
EKSO N/M vs PLSE N/M Fwd P/E
Growth & Margin Winner
PLSE
Op Margin -119.7% vs -5861.2% ยท YoY -38.3% vs +359.3%
Momentum & Technical Winner
PLSE
1Y +62.6% vs +250.1% ยท 52W Pos 87% vs 71%
Options & Structure Winner
PLSE
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (10th %ile IV)
EKSO
NASDAQ
Ekso Bionics Holdings, Inc. Common Stock
General Industrial Machinery & Equipment, Nec
$11.80
+0.08% 1D
Market Cap
$42.0M
1M Return
+25.53%
1Y Return
+62.6%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 60.0
Fund 54.0
Flow 50.0
Mom 50.0
PLSE
NASDAQ
Pulse Biosciences, Inc Common Stock (DE)
Surgical & Medical Instruments & Apparatus
$45.55
+2.57% 1D
Market Cap
$3.3B
1M Return
-13.53%
1Y Return
+250.12%
Forward P/E
N/M
Unified AI Score
64.2 / 100
BUY
Tech 63.0
Fund 60.0
Flow 65.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EKSO +62.6%
PLSE +250.12%
Spread: +138.84 pp (EKSO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EKSO TTM Op. Margin: -119.7%
PLSE TTM Op. Margin: -5861.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EKSO vs PLSE. Trailing 12-month operating profitability (EKSO -119.7% vs PLSE -5861.2%) and valuation multiples (EKSO N/M vs PLSE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EKSO | PLSE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $42.0M | $3.3B | Larger Scale | PLSE |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -38.3% | +359.3% | Higher Growth | PLSE |
| Operating Margin (TTM) Profitability | -119.7% | -5861.2% | Higher Margin | EKSO |
| Net Profit Margin Profitability | -91.4% | 0.0% | Higher Margin | PLSE |
| Return on Equity (ROE) Capital Efficiency | -107.6% | -60.6% | Higher ROE | PLSE |
| 52-Week Range Position Momentum | 87% ($0โ$14) | 71% ($13โ$59) | Stronger Trend | EKSO |
| Beta / 30D Volatility Risk Regime | 2.16ฮฒ ยท 76% Vol | 1.71ฮฒ ยท 76% Vol | Lower Realized Risk | Tie |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 64.2 / 100 (BUY) | Higher Composite | PLSE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EKSO vs PLSE Buy Guide
EKSO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PLSE
CONSOLIDATION
55d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EKSO nor PLSE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.